143 related articles for article (PubMed ID: 24008930)
1. Comparison of interleukin-17- producing cells in different clinical types of alopecia areata.
Tojo G; Fujimura T; Kawano M; Ogasawara K; Kambayashi Y; Furudate S; Mizuashi M; Aiba S
Dermatology; 2013; 227(1):78-82. PubMed ID: 24008930
[TBL] [Abstract][Full Text] [Related]
2. Serum granulysin as a possible key marker of the activity of alopecia areata.
Ono S; Otsuka A; Yamamoto Y; Kataoka TR; Koyanagi I; Miyachi Y; Kabashima K
J Dermatol Sci; 2014 Jan; 73(1):74-9. PubMed ID: 24035442
[TBL] [Abstract][Full Text] [Related]
3. Dissecting susceptibility from exogenous triggers: the model of alopecia areata and associated inflammatory skin diseases.
Garzorz N; Alsisi M; Todorova A; Atenhan A; Thomas J; Lauffer F; Ring J; Schmidt-Weber C; Biedermann T; Eyerich S; Eyerich K
J Eur Acad Dermatol Venereol; 2015 Dec; 29(12):2429-35. PubMed ID: 26416203
[TBL] [Abstract][Full Text] [Related]
4. B cell activating factor and T-helper 17 cells: possible synergistic culprits in the pathogenesis of Alopecia Areata.
Elela MA; Gawdat HI; Hegazy RA; Fawzy MM; Abdel Hay RM; Saadi D; Shaker O
Arch Dermatol Res; 2016 Mar; 308(2):115-21. PubMed ID: 26796544
[TBL] [Abstract][Full Text] [Related]
5. Alopecia areata: infiltration of Th17 cells in the dermis, particularly around hair follicles.
Tanemura A; Oiso N; Nakano M; Itoi S; Kawada A; Katayama I
Dermatology; 2013; 226(4):333-6. PubMed ID: 23838575
[TBL] [Abstract][Full Text] [Related]
6. T-helper and regulatory T-cell cytokines in the peripheral blood of patients with active alopecia areata.
Tembhre MK; Sharma VK
Br J Dermatol; 2013 Sep; 169(3):543-8. PubMed ID: 23607748
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-2 receptor alpha-chain expression in patients with alopecia areata.
Brajac I; Gruber F; Petrovecki M; Malnar-Dragojević D
Acta Dermatovenerol Croat; 2004; 12(3):154-6. PubMed ID: 15369638
[TBL] [Abstract][Full Text] [Related]
8. Interferon-gamma-deficient mice are resistant to the development of alopecia areata.
Freyschmidt-Paul P; McElwee KJ; Hoffmann R; Sundberg JP; Vitacolonna M; Kissling S; Zöller M
Br J Dermatol; 2006 Sep; 155(3):515-21. PubMed ID: 16911275
[TBL] [Abstract][Full Text] [Related]
9. Combination therapy with oral PUVA and corticosteroid for recalcitrant alopecia areata.
Ito T; Aoshima M; Ito N; Uchiyama I; Sakamoto K; Kawamura T; Yagi H; Hashizume H; Takigawa M
Arch Dermatol Res; 2009 Jun; 301(5):373-80. PubMed ID: 19301021
[TBL] [Abstract][Full Text] [Related]
10. Imbalance of T-helper 17 and regulatory T cells in patients with alopecia areata.
Han YM; Sheng YY; Xu F; Qi SS; Liu XJ; Hu RM; Miao Y; Huang GQ; Yang QP
J Dermatol; 2015 Oct; 42(10):981-8. PubMed ID: 26077574
[TBL] [Abstract][Full Text] [Related]
11. Skin-infiltrating T cells and cytokine expression in Icelandic horses affected with insect bite hypersensitivity: a possible role for regulatory T cells.
Heimann M; Janda J; Sigurdardottir OG; Svansson V; Klukowska J; von Tscharner C; Doherr M; Broström H; Andersson LS; Einarsson S; Marti E; Torsteinsdottir S
Vet Immunol Immunopathol; 2011 Mar; 140(1-2):63-74. PubMed ID: 21168921
[TBL] [Abstract][Full Text] [Related]
12. Impaired inhibitory function of circulating CD4+CD25+ regulatory T cells in alopecia areata.
Shin BS; Furuhashi T; Nakamura M; Torii K; Morita A
J Dermatol Sci; 2013 May; 70(2):141-3. PubMed ID: 23433552
[No Abstract] [Full Text] [Related]
13. Phenotypic analysis of T-cells in extensive alopecia areata scalp suggests partial tolerance.
Deeths MJ; Endrizzi BT; Irvin ML; Steiner LP; Ericson ME; Hordinsky MK
J Invest Dermatol; 2006 Feb; 126(2):366-73. PubMed ID: 16374469
[TBL] [Abstract][Full Text] [Related]
14. Role of T helper 17 cells and T regulatory cells in alopecia areata: comparison of lesion and serum cytokine between controls and patients.
Loh SH; Moon HN; Lew BL; Sim WY
J Eur Acad Dermatol Venereol; 2018 Jun; 32(6):1028-1033. PubMed ID: 29283462
[TBL] [Abstract][Full Text] [Related]
15. Activated and resting regulatory T cell exhaustion concurs with high levels of interleukin-22 expression in systemic sclerosis lesions.
Mathian A; Parizot C; Dorgham K; Trad S; Arnaud L; Larsen M; Miyara M; Hié M; Piette JC; Frances C; Yssel H; Amoura Z; Gorochov G
Ann Rheum Dis; 2012 Jul; 71(7):1227-34. PubMed ID: 22696687
[TBL] [Abstract][Full Text] [Related]
16. The association between Interleukin (IL)-4 gene intron 3 VNTR polymorphism and alopecia areata (AA) in Turkish population.
Kalkan G; Karakus N; Baş Y; Takçı Z; Ozuğuz P; Ateş O; Yigit S
Gene; 2013 Sep; 527(2):565-9. PubMed ID: 23831512
[TBL] [Abstract][Full Text] [Related]
17. Serum T helper 1 cytokine levels are greater in patients with alopecia areata regardless of severity or atopy.
Barahmani N; Lopez A; Babu D; Hernandez M; Donley SE; Duvic M
Clin Exp Dermatol; 2010 Jun; 35(4):409-16. PubMed ID: 19874320
[TBL] [Abstract][Full Text] [Related]
18. Apoptosis resistance in peripheral blood lymphocytes of alopecia areata patients.
Zöller M; McElwee KJ; Vitacolonna M; Hoffmann R
J Autoimmun; 2004 Nov; 23(3):241-56. PubMed ID: 15501395
[TBL] [Abstract][Full Text] [Related]
19. In vivo levels of IL-4, IL-10, TGF-beta1 and IFN-gamma mRNA of the peripheral blood mononuclear cells in patients with alopecia areata in comparison to those in patients with atopic dermatitis.
Katagiri K; Arakawa S; Hatano Y
Arch Dermatol Res; 2007 Jan; 298(8):397-401. PubMed ID: 17021766
[TBL] [Abstract][Full Text] [Related]
20. Expression of vascular endothelial growth factor, apoptosis inhibitors (survivin and p16) and CCL27 in alopecia areata before and after diphencyprone treatment: an immunohistochemical study.
Simonetti O; Lucarini G; Bernardini ML; Simoncini C; Biagini G; Offidani A
Br J Dermatol; 2004 May; 150(5):940-8. PubMed ID: 15149507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
